EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PCSK9 vaccines: a promising new strategy for the treatment of hypercholesterolemia?

Bryce Chackerian, Alan T Remaley

Journal of Lipid Research · 2024-03 · 65 (3) · 100524

DOI: 10.1016/j.jlr.2024.100524 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Lipid Research, 2024-03. Verfasst von Bryce Chackerian und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, NM, USA. Electronic address: BChackerian…. Hauptthemen laut MEDLINE: Hypercholesterolemia, Anticholesteremic Agents, Vaccines, Hyperlipidemias. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Heart Lung and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Management of elevated LDL-C, a causal risk factor in the development of atherosclerotic cardiovascular disease (ASCVD), has been revolutionized by using inhibitors of proprotein convertase subtilisin/kexin type 9 (PCSK9). When used in conjunction with statins, PCSK9 inhibitors can markedly lower LDL-C to levels that have not been previously attained with other lipid-lowering medications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypercholesterolemiaAnticholesteremic AgentsVaccinesHyperlipidemiasHumansProprotein Convertase 9Cholesterol, LDL

Substanzen

PCSK9 protein, humanProprotein Convertase 9Cholesterol, LDLAnticholesteremic AgentsVaccines

Autor:innen und Institutionen

  • Department of Molecular Genetics and Microbiology, University of New Mexico School of Medicine, Albuquerque, NM, USA. Electronic address: BChackerian@salud.unm.edu.
  • Lipoprotein Metabolism Laboratory, Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.

Förderung

  • National Heart Lung and Blood Institute

Zitieren

APA

Chackerian, B., & Remaley, A. T. (2024). PCSK9 vaccines: a promising new strategy for the treatment of hypercholesterolemia?. Journal of Lipid Research, 65(3), 100524. https://doi.org/10.1016/j.jlr.2024.100524

Vancouver

Chackerian B, Remaley AT. PCSK9 vaccines: a promising new strategy for the treatment of hypercholesterolemia?. Journal of Lipid Research. 2024;65(3):100524. doi:10.1016/j.jlr.2024.100524

BibTeX
@article{Chackerian2024,
  author = {Chackerian, Bryce and Remaley, Alan T},
  title = {PCSK9 vaccines: a promising new strategy for the treatment of hypercholesterolemia?},
  journal = {Journal of Lipid Research},
  year = {2024},
  volume = {65},
  number = {3},
  pages = {100524},
  doi = {10.1016/j.jlr.2024.100524}
}
Kostenlos starten →